These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9818177)

  • 21. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
    Zolkiewska A
    Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.
    Cao Y; Kang Q; Zolkiewska A
    Biochem J; 2001 Jul; 357(Pt 2):353-61. PubMed ID: 11439084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
    Moss ML; Jin SL; Milla ME; Bickett DM; Burkhart W; Carter HL; Chen WJ; Clay WC; Didsbury JR; Hassler D; Hoffman CR; Kost TA; Lambert MH; Leesnitzer MA; McCauley P; McGeehan G; Mitchell J; Moyer M; Pahel G; Rocque W; Overton LK; Schoenen F; Seaton T; Su JL; Becherer JD
    Nature; 1997 Feb; 385(6618):733-6. PubMed ID: 9034191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure.
    Fahrenholz F; Gilbert S; Kojro E; Lammich S; Postina R
    Ann N Y Acad Sci; 2000; 920():215-22. PubMed ID: 11193153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.
    Loechel F; Fox JW; Murphy G; Albrechtsen R; Wewer UM
    Biochem Biophys Res Commun; 2000 Nov; 278(3):511-5. PubMed ID: 11095942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shedding growth factors in cardiac hypertrophy.
    Liao JK
    Nat Med; 2002 Jan; 8(1):20-1. PubMed ID: 11786898
    [No Abstract]   [Full Text] [Related]  

  • 27. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
    Shi Z; Xu W; Loechel F; Wewer UM; Murphy LJ
    J Biol Chem; 2000 Jun; 275(24):18574-80. PubMed ID: 10849447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shedding light on sheddases: role in growth and development.
    Kheradmand F; Werb Z
    Bioessays; 2002 Jan; 24(1):8-12. PubMed ID: 11782944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta.
    Wei P; Zhao YG; Zhuang L; Ruben S; Sang QX
    Biochem Biophys Res Commun; 2001 Jan; 280(3):744-55. PubMed ID: 11162584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10.
    Manzetti S; McCulloch DR; Herington AC; van der Spoel D
    J Comput Aided Mol Des; 2003 Sep; 17(9):551-65. PubMed ID: 14713188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria.
    Arndt M; Lendeckel U; Röcken C; Nepple K; Wolke C; Spiess A; Huth C; Ansorge S; Klein HU; Goette A
    Circulation; 2002 Feb; 105(6):720-5. PubMed ID: 11839628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins.
    Jia LG; Shimokawa K; Bjarnason JB; Fox JW
    Toxicon; 1996; 34(11-12):1269-76. PubMed ID: 9027982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
    Black RA; Rauch CT; Kozlosky CJ; Peschon JJ; Slack JL; Wolfson MF; Castner BJ; Stocking KL; Reddy P; Srinivasan S; Nelson N; Boiani N; Schooley KA; Gerhart M; Davis R; Fitzner JN; Johnson RS; Paxton RJ; March CJ; Cerretti DP
    Nature; 1997 Feb; 385(6618):729-33. PubMed ID: 9034190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs.
    Amour A; Knight CG; English WR; Webster A; Slocombe PM; Knäuper V; Docherty AJ; Becherer JD; Blobel CP; Murphy G
    FEBS Lett; 2002 Jul; 524(1-3):154-8. PubMed ID: 12135759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cysteine-rich domain regulates ADAM protease function in vivo.
    Smith KM; Gaultier A; Cousin H; Alfandari D; White JM; DeSimone DW
    J Cell Biol; 2002 Dec; 159(5):893-902. PubMed ID: 12460986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unidirectional Notch signaling depends on continuous cleavage of Delta.
    Sapir A; Assa-Kunik E; Tsruya R; Schejter E; Shilo BZ
    Development; 2005 Jan; 132(1):123-32. PubMed ID: 15576412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular, biochemical, and cellular characterization of epididymal ADAMs, ADAM7 and ADAM28.
    Oh J; Woo JM; Choi E; Kim T; Cho BN; Park ZY; Kim YC; Kim DH; Cho C
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1374-83. PubMed ID: 15883027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAM family proteins in the immune system.
    Yamamoto S; Higuchi Y; Yoshiyama K; Shimizu E; Kataoka M; Hijiya N; Matsuura K
    Immunol Today; 1999 Jun; 20(6):278-84. PubMed ID: 10354553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMP regulates Kuzbanian to control the timing of Notch signalling in
    Fic W; Faria C; St Johnston D
    Development; 2019 Jan; 146(2):. PubMed ID: 30635283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.